N ‐Substituted Bridged Azaozonides as Promising Antimalarial Agents
ChemMedChem · 2025
DOI: 10.1002/cmdc.202500181 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Paolo Coghi und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Macau University Science and Technology, Avenida Wai Long, Taipa, Macau, 999078, China. Hauptthemen laut MEDLINE: Antimalarials, Plasmodium falciparum, Antineoplastic Agents, Aza Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Fundo para o Desenvolvimento das Ciências e da Tecnologia, Thailand National Science and Technology Development Agency, National Center for Genetic Engineering and Biotechnology and Thailand Research Fund.
Abstract (Originalsprache)
Forty‐five aminoperoxides belonging to bridged azaozonides, bridged N ‐substituted azaozonides, and tricyclic aminoperoxides were evaluated for in vitro antimalarial activity against Plasmodium falciparum (3D7) and for cytotoxicity against immortalized human normal liver (LO 2 ) and lung (BEAS‐2B) cell lines, as well as human liver (HepG2) and lung (A549) cancer cell lines. Seven N ‐substituted azaozonides exhibited high antimalarial activity against the chloroquine‐sensitive 3D7 strain of P. falciparum , with IC 50 < 1 μM. The lead compound 22 showed IC 50 = 0.07 μM and selectivity index of 1428. Most aminoperoxides were generally non‐cytotoxic to both normal and cancer liver and lung cells. Only two azaozonides exhibited moderate cytotoxicity on HepG2 cell line ( 2 : IC 50 = 4.12 μM, 40 : 9.95 μM), while one azaozonide 2 had an IC 50 = 5.56 μM against A549 cell line. From this small library of 45 aminoperoxides, compound 22 was found to have antimalarial activity comparable to artemisinin and chloroquine used in medical practice. These findings provide a new source for developing antimalarial agents through structural modification of aminoperoxide compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Macau University Science and Technology, Avenida Wai Long, Taipa, Macau, 999078, China.
- Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, 999078, China.
- N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospect 47, Moscow, 119991, Russian Federation.
- National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), 113 Thailand Science Park, Pathum Thani, 12120, Thailand.
- Institute of Laboratory Medicine, School of Medical University, Guangdong Medical University, Dongguan, 523808, China.
ORCID-Profile: Paolo Coghi, Ivan A Yaremenko, Yulia Yu Belyakova, Peter S Radulov, Chairat Uthaipibull, Alexander O Terent'ev, Vincent Kam Wai Wong
Förderung
- Fundo para o Desenvolvimento das Ciências e da Tecnologia
- Thailand National Science and Technology Development Agency
- National Center for Genetic Engineering and Biotechnology and Thailand Research Fund
- Macau University of Science and Technology
- Russian Science Foundation
Zitieren
APA
Coghi, P., Yaremenko, I. A., Prommana, P., Nasim, A. A., Belyakova, Y. Y., Chen, R., Radulov, P. S., Uthaipibull, C., Terent'ev, A. O., & Wong, V. K. W. (2025). N ‐Substituted Bridged Azaozonides as Promising Antimalarial Agents. ChemMedChem. https://doi.org/10.1002/cmdc.202500181
Vancouver
Coghi P, Yaremenko IA, Prommana P, Nasim AA, Belyakova YY, Chen R, et al. N ‐Substituted Bridged Azaozonides as Promising Antimalarial Agents. ChemMedChem. 2025. doi:10.1002/cmdc.202500181
BibTeX
@article{Coghi2025,
author = {Coghi, Paolo and Yaremenko, Ivan A and Prommana, Parichat and Nasim, Ali Adnan and Belyakova, Yulia Yu and Chen, Ruihong and Radulov, Peter S and Uthaipibull, Chairat and Terent'ev, Alexander O and Wong, Vincent Kam Wai},
title = {N ‐Substituted Bridged Azaozonides as Promising Antimalarial Agents},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202500181}
}
EUVIMED